| Avelita Dela Cruz, | |
|
7105 50th Ave N, St Petersburg, FL 33709-2701 | |
| (727) 674-5063 | |
| Not Available |
| Full Name | Avelita Dela Cruz |
|---|---|
| Gender | Female |
| Speciality | Day Training, Developmentally Disabled Services |
| Location | 7105 50th Ave N, St Petersburg, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366106544 | NPI | - | NPPES |
| 691998796 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 1244461 (Florida) | Secondary |
| 251C00000X | Day Training, Developmentally Disabled Services | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Avelita Dela Cruz, 7105 50th Ave N, St Petersburg, FL 33709-2701 Ph: (727) 674-5063 | Avelita Dela Cruz, 7105 50th Ave N, St Petersburg, FL 33709-2701 Ph: (727) 674-5063 |
News Archive
Addressing the relentless game of cat and mouse played between antibiotics and bacteria, a pair of University of Houston professors recently received a $519,000 grant from the National Institutes of Health.
The UK National Health Service could save millions of pounds a year by routinely using inexpensive dressings to treat venous leg ulcers, after a study published in the October issue of BJS showed that they are just as effective as expensive silver dressings in the majority of cases.
Marsha Trotter from Pike County, Ala., expresses her concerns to Alabama freshman Rep. Bobby Bright at a town hall meeting. The retired teacher said she fears that new health care plans would require her to meet with a government board to discuss end-of-life options. "Now that's my life and my business, and I don't want the government in it," she said. (Debbie Elliott/NPR)
OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.
› Verified 9 days ago